Filters

Xinhong Guo

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Nano Letters|January 8, 2026
Electrochemically Dissociated Highly Compact Porous Carbon as a High-Capacity Capacitive Cathode for Lithium-Ion CapacitorsHao Ning, Xinhong Guo, Xiaobo Yang, et al.
Platelets|January 3, 2023
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics studyXiaofan Liu, Yusheng Bai, Tao Wang, et al.
Journal of Translational Internal Medicine|December 22, 2023
Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trialHu Zhou, Shouqing Han, Jie Jin, et al.
American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.
The Lancet. Haematology|June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyYu Hu, Xiaofan Liu, Hu Zhou, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Nano Letters|January 8, 2026
Electrochemically Dissociated Highly Compact Porous Carbon as a High-Capacity Capacitive Cathode for Lithium-Ion CapacitorsHao Ning, Xinhong Guo, Xiaobo Yang, et al.
Platelets|January 3, 2023
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics studyXiaofan Liu, Yusheng Bai, Tao Wang, et al.
Journal of Translational Internal Medicine|December 22, 2023
Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trialHu Zhou, Shouqing Han, Jie Jin, et al.
American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.
The Lancet. Haematology|June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyYu Hu, Xiaofan Liu, Hu Zhou, et al.
Pageof 11
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us